This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.
News|Articles|January 6, 2026
Reactions to the CDC changing the childhood vaccine schedule
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Morgan Ebert, Executive Editor, Justin Mancini
Reactions from the pediatric health care community poured in following swift changes to the US childhood vaccine schedule by the CDC.
Advertisement
Advertisement
Following the CDC's shake-up of the United States' childhood vaccine schedule, many experts and medical societies in the pediatric infectious diseases space have voiced their concerns with the vaccine recommendation changes.1
Related to this article
AAP guidance expands RSV immunization eligibility for children aged 8 through 19 months at high risk of severe disease.
Five rapid developments — new mRNA flu vaccine, CDC director, ACIP/NVAC charters, a vaccine order, and an HHS RFI — roil the 2026 schedule.
Court fight over CDC 2026 childhood vaccine schedule shifts shots to shared decision-making; experts warn lower uptake for Hep A, B, flu, COVID.
New evidence supports influenza, COVID-19, and RSV immunizations for reducing severe respiratory illness and hospitalization.
CDC's 2025 NIS-Teen data show HPV vaccine coverage flat for a fourth year, with rural adolescents 12 points behind urban peers in receiving ≥1 dose.
The AAP's 2026-2027 policy recommends universal vaccination for infants 6-23 months and a risk-based single dose for children 2-18 years.
Lori Handy, MD, says vaccine conversations with hesitant families should prioritize trust, follow-up, and the benefits for the individual child.
Advertisement
Advertisement